Genetco Inc Ronkonkoma, NY - 11779

Genetco Inc is categorized under Pharmaceutical Manufacturing Plant Construction in Ronkonkoma, NY and active since 1986.

Genetco Inc was established in 1986, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 3391120 by the NAICS.

If you are seeking more information, feel free to contact Carol Reinbold, Owner at the company’s single location by writing to 711 Union Parkway, Ronkonkoma, New York NY 11779 or by phoning (631) 913-0395. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genetco Inc
Contact Person: Carol Reinbold, Owner
Address: 711 Union Parkway, Ronkonkoma, New York 11779
Phone Number: (631) 913-0395
Website Address: genetcoinc.com
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 1986
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Pharmaceutical Manufacturing Plant Construction
SIC Code: 1541
NAICS Code: 3391120
Share This Business:

Genetco Inc was started in 1986 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Carol Reinbold, Owner for inquiries that concern Genetco Inc by calling the company number (631) 913-0395, as your correspondence is most welcome. Additionally, the physical location of the single location of Genetco Inc can be found at the coordinates 40.79217,-73.12042 as well as the street address 711 Union Parkway in Ronkonkoma, New York 11779.

For its online presence, you may visit Genetco Inc’s website at genetcoinc.com and engage with its social media outlets through on Twitter and on Facebook.